Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Hemasphere|February 16, 2026
Deep cytomorphology identifies erythroid skewing and monocytic morphology to predict TKI sensitivity in CML patientsKatariina Luukkainen, Mikko Purhonen, Mikael Tatun, et al.
Leukemia & Lymphoma|October 27, 2006
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phaseUlla Olsson-Strömberg, Martin Höglund, Magnus Björkholm, et al.
Leukemia|July 10, 2024
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI TrialFabio Efficace, Francois-Xavier Mahon, Johan Richter, et al.
The Journal of Clinical Investigation|September 1, 2022
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemiaJani Huuhtanen, Mette Ilander, Bhagwan Yadav, et al.
The Lancet. Oncology|May 9, 2018
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trialSusanne Saussele, Johan Richter, Joelle Guilhot, et al.
Leukemia|July 1, 2020
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemiaMarkus Pfirrmann, Richard E Clark, Witold Prejzner, et al.
Blood|April 5, 2023
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic optionMonika Dolinska, Huan Cai, Alma Månsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free RemissionFrancois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq, et al.
Pageof 5